Exhibitors Relations
@ERCboxoffice
DOCTOR STRANGE Int'l docket: KOR ($18M) UK ($11M) FRA ($5.7M) OZ ($4.9M) GER ($4.8M) MEX ($4.6M) TAI ($4.3M) HK ($3.2M)
International highlights start with the release of Disney and Marvel's Doctor Strange, which delivered an estimated $86 million in its international debut in 33 territories, comprising 45% of the international marketplace. Compared to previous openings in the Marvel Cinematic Universe this opening is +49% ahead of Ant-Man, +37% ahead of Guardians of the Galaxy, +23% ahead of Captain America: Winter Soldier and +1% ahead of Thor: The Dark World when comparing the same suite of territories and all at today's exchange rates.
Top territories include South Korea ($18.1m), UK ($11.1m), France ($5.7m), Australia ($4.9m), Germany ($4.8m), Mexico ($4.6m), Taiwan ($4.3m), Hong Kong ($3.2m), Indonesia ($3.1m), Philippines ($2.7m), Italy ($2.5m), Thailand ($2.5m), Russia ($2.5m), Malaysia ($2.4m), Singapore ($2.2m) and Spain ($2.2m).
Doctor Strange will debut domestically next weekend in ~3,800 theaters as well has hit theaters in Russia, Brazil, China, Colombia and several other overseas markets.
IMAX screens contributed $7.8 million from 213 locations across 32 countries. This makes it IMAX’s biggest October opener of all time internationally, more than doubling the previous $3.2 million record set by Gravity. It is the biggest IMAX bow of all time in South Korea. It will expand to an additional 787 IMAX locations next weekend, including North America and China —the world’s top two markets— which will make it the first IMAX title to ever play in over 1000 screens and the widest IMAX release of all time.
I'm loving how well this is doing so far.
Total Lifetime Grosses
Domestic: n/a 0.0%
+ Foreign: $87,745,399 100.0%
= Worldwide: $87,745,399
Exhibitors are holding out for a hero this weekend, and that caped wonder is Disney/Marvel’s Doctor Strange, who is expected to save the fall box office from its atrocious 10% lag from the same post-Labor Day-to-Halloween period a year ago. Doctor Strange is the second live-action Marvel title after Thor: The Dark World to play the late fall season, specifically November, and it’s looking to make $65M to potentially mid-$70M over three days at 3,882 venues.
Isn't 300m domestic the new blockbuster break out number?It needs to open closer to 80M to get a decent shot at 200M with the upcoming competition.
Australian numbers are usually quite reliable to predict domestic opening week end and unfortunately they seem to point out to Strange missing 80M.
80M/200M+ dom aren't the be all and end all numbers (especially if displays a decent holding power over the coming weeks) but so far it looks like it's gonna fall short of being another breakout hit for Marvel. A decent sized hit sure, but not a breakout ala GotG or CATWS.
Isn't 300m domestic the new blockbuster break out number?
That makes sense. If Doctor Strange gets to 500m, no matter the breakdown, I think that will be considered good news.Depends on the IP I guess.